The article says the companies “will develop a biosimilar for a brand biological drug which currently has billions of dollars in annual sales.” Humira certainly qualifies on that score!
p.s. UTR is Norwegian, not Swedish.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.